Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway-MedSci.cn

Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway

Yang, WB; Zhang, AD; Han, YX; Su, XX; Chen, YJ; Zhao, WL; Yang, K; Jin, W

Yang, K; Jin, W (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Cardiol, Sch Med, 197,Ruijin 2nd Rd, Shanghai 200025, Peoples R China.; Yang, K (corresponding author), Shanghai Jiao Tong Univ, Inst Cardiovasc Dis, Sch Med, 197,Ruijin 2nd Rd, Shanghai 200025, Peoples R China.

Abstract

Background: Cardiac fibrosis is an important cause of heart failure (HF) after myocardial infarction (MI). Cyclin-dependent kinase inhibitor 2b (CDKN2......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway

科室

工具

服务